发明名称 CRYSTALLINE FORMS OF ALKOXYIMIDAZOL-1-YLMETHYL BIPHENYL CARBOXYLIC ACID
摘要 PROBLEM TO BE SOLVED: To provide novel crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid, which has angiotensin II type 1 receptor antagonist activity and neprilysin-inhibition activity and is used for treating hypertension or heart failure.SOLUTION: The invention provides crystalline heminapadisylate salt or oxalate salt of 4'-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]-imidazol-1-ylmethyl}-3'-fluorobiphenyl-2-carboxylic acid represented by formula (I) characterized by a powder x-ray diffraction pattern comprising specific diffraction peaks.SELECTED DRAWING: None
申请公布号 JP2016028061(A) 申请公布日期 2016.02.25
申请号 JP20150174397 申请日期 2015.09.04
申请人 THERAVANCE BIOPHARMA R&D IP LLC 发明人 ポール アール. ファザリー;ヴァンキャット アール. サラディー
分类号 C07D233/70;A61K31/4174;A61K45/00;A61P9/04;A61P9/12;A61P43/00;C07C51/41;C07C55/07;C07C303/32;C07C309/05;C07C309/34 主分类号 C07D233/70
代理机构 代理人
主权项
地址